Prognostic value of estrogen receptor status can be improved by combined evaluation of p53, Bcl2 and PgR expression: an immunohistochemical study on breast carcinoma with long-term follow-up.

International journal of oncology

Volumn 15, Issue 6, 1999, Pages 1137-1147

  Mauri, F A ^a   Maisonneuve, P ^a   Caffo, O ^a   Veronese, S ^a   Aldovini, D ^a   Ferrero, S ^a   Cozzaglio, F ^a   Dalla Palma, P ^a   Galligioni, E ^a   Barbareschi, M ^a  

^a SS Trinità Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; SURVIVAL; TIME; TUMOR RECURRENCE;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

MLCS; MLOWN;

EID: 0033450489     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.15.6.1137     Document Type: Article

References (0)